United Kingdom

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

10:20am GMT
Change (% chg)

-0.75kr (-0.71%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Getinge sets new financial targets after distribution of Arjo
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Getinge :Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo).Says ‍focus is on organic growth and Getinge foresees an organic market growth of 2-4% on average during 2017-2020 in addressable market​.Says ‍Getinge's organic growth in net sales is expected to increase gradually during 2018 and move closer to expected market growth on a run-rate basis by end of 2018​.Says targets ‍average growth in organic net sales: 2-4%​.Says ‍targets average earnings per share growth: >10%​.Says ‍dividend policy: 30-50% of net income.Getinge is distributing the Patient & Post-Acute Care business area​ into a separately listed company called Arjo.Says Arjo's shares of series B will be listed on Nasdaq Stockholm on December 12, 2017.  Full Article

Getinge Q3 core profit lags expectations, targets PPAC listing by year-end ​
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Getinge :Q3 ‍order intake increased by 2.2% to sek 7,334 m (7,176). Order intake increased organically by 4.7%.​.Getinge q3 - ‍net sales fell by 3.4% to sek 6,696 m (6,929). Net sales decreased organically by 0.7%.​.Q3 ‍ebita 1* declined by 31.6% to sek 659 m​.Getinge says organic sales growth is expected to be slightly positive in 2017.‍​.Getinge says currency transaction effects are expected to have a positive impact of approximately sek 250 m on getinge’s 2017 ebit‍​.Reuters poll: getinge q3 order intake was seen at 7.2 billion sek, adjusted. Ebita at 904 million.Says ‍net sales were adversely impacted by lower order intake in q2 and higher expenses partly related to work on preparing proposed distribution of patient & post-acute care business area​.Getinge says remainder of 2017 will be challenging, partly because the fourth quarter is our most important quarter in terms of sales and profitability, and partly because we have large-scale projects to complete before the start of 2018‍​.Getinge says aim is to distribute and list ppac division before end of year, on condition of a decision by the board and the approval of an extraordinary general meeting‍​.  Full Article

Getinge sees 2017 organic growth in lower half of 0-2 pct guidance range - CEO
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Getinge Ab CEO Mattias Perjos in conference call with analysts and media: :says sees f/y 2017 organic sales growth in lower half of 0-2 percent guidance range.  Full Article

Getinge fires chief executive
Monday, 22 Aug 2016 

Getinge : Replacement of president & CEO getinge group:Joacim Lindoff appointed acting president & CEO of Getinge Group . Says President & CEO Alex Myers is leaving his position . Says change will be effective as of today . Says Board of Directors and Alex Myers have different views on the future direction of the Getinge Group and the board has therefore concluded that a replacement of the President & CEO is necessary . Says process to recruit a new president & CEO of the Getinge Group will commence immediately .Lindoff recently served as executive vice president of the business area Infection Control and has since January 1, 2016, headed up Getinge Surgical Workflows and is a member of the executive team.  Full Article

Getinge: 2016 sales growth outlook is unchanged, only wording differs vs Q1 report
Thursday, 14 Jul 2016 

Getinge Ab : Spokesperson says only wording of 2016 outlook is changed, view of sales growth is unchanged compared to Q1 report Further company coverage: [GETIb.ST] ((Sven.Nordenstam@thomsonreuters.com;)).  Full Article

Getinge Q2 core profit, order intake below forecasts
Thursday, 14 Jul 2016 

Getinge : Q2 order intake: -0.7 pct to sek 7,460 m (7,516). Order intake grew organically by 3.0 pct. . Q2 net sales: -3.5 pct to sek 6,927 m (7,181). Net sales fell organically by 0.3 pct . Q2 adjusted EBITA: +10.2 pct to sek 788 m . Reuters poll: Q2 order intake was seen at 7,546 mln sek, adjusted EBITA at 867 mln . Says is still awaiting a decision by FDA regarding remediation plan in Hechingen . Says outlook changed . Says expects moderate organic sales growth in 2016 .Previous sales outlook was "All in all, revenue growth is deemed to be positive in 2016.".  Full Article

Templeton Global Advisors cuts Getinge stake to 4.88 percent of votes
Thursday, 2 Jun 2016 

Getinge Ab :Templeton Global Advisors, Ltd cuts stake to 4.88 percent of votes, a FSA filing shows on Thursday.  Full Article

UPDATE 2-Chipmakers, Sanofi deal dominate European share trading

* Bond yield rise hits income stocks, utilities (Adds prices, details)